CAMBRIDGE, Mass., March 26, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnologycompany developing IPI-549, a potentially first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), today announced that management will be presenting at the following two upcoming conferences:
Needham & Company Annual Healthcare Conference:Lawrence Bloch, M.D., J.D., Infinity's President, will present at Needham & Company's 17th Annual Healthcare Conference on Tuesday, March 27, 2018, at 11:00 a.m. ET at the Westin NY Grand Central Hotel in New York, NY. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.
8th Annual Cancer and Immunotherapy Conference: Jeffery Kutok, M.D., Ph.D., Infinity's Chief Scientific Officer, will present during the "The Tumor Microenvironment in Cancer: Reevaluating Checkpoints on Suppressive Myeloid Cells," session at the 8th Annual Cancer and Immunotherapy Conference hosted by William Blair & Company and MaidStone Life Sciences on April 5, 2018, at 10:40 a.m. ET at the Apella Event Space Alexandria Center, New York, NY.
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-two-upcoming-conferences-300619141.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Menstruation or period is the discharge of blood and mucus called menses from the uterus via the ...
Chronic dieting is associated with eating disorders that mainly include unhealthy eating practices ...
Some medications affect the normal function of thyroid gland leading to thyroid function disorders ...View All